Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02151032
Other study ID # 2011-0632
Secondary ID 0619-1
Status Completed
Phase
First received
Last updated
Start date November 2012
Est. completion date May 19, 2020

Study information

Verified date November 2023
Source M.D. Anderson Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this research study is to compare how people who are 45-75 years old respond to 3 different versions of a program about screening tests for colorectal cancer. Researchers want to use this study as part of a long-term project to learn the best ways to communicate health information to patients.


Description:

If you agree to take part in this study, you will be randomly assigned (as in a roll of dice) to 1 of 3 study groups. Neither you nor the study staff will be able to choose which group you will be in: - If you are in Group 1, you will read a booklet about colorectal cancer screening tests. While reading the booklet, you will also listen to an audio CD that will narrate the booklet. - If you are in Group 2, you will watch a video with non-moving images about colorectal cancer screening tests on an iPad. - If you are in Group 3, you will watch a video with animated images about colorectal cancer screening tests on an iPad. You will complete questionnaires before and after viewing the program that will contain questions about: - Your age and what language you speak - Your math and reading comprehension - Your knowledge of colorectal cancer and colorectal cancer screening - Your thoughts about colorectal cancer screening - Your opinions about this study, and - How well you understand the booklet/video you view as part of this study It will take about 1 hour to complete all the questionnaires. In total, the study will take about 1 ½ to 2 hours to complete. After you have completed the questionnaires, your participation in the study will be over. This is an investigational study. Up to 201 people will take part in this multicenter study. Up to 67 will be enrolled at MD Anderson.


Recruitment information / eligibility

Status Completed
Enrollment 189
Est. completion date May 19, 2020
Est. primary completion date May 19, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 75 Years
Eligibility Inclusion Criteria: 1. Men and women 45 to 75 years of age. 2. Participant must speak English. Exclusion Criteria: 1) Self-reported diagnosis of colon cancer.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Booklet
Participants read a booklet about colorectal cancer screening tests.
Audio CD
Participants listen to an audio CD that will narrate the colorectal cancer screening tests booklet.
Video with Non-Moving Images
Participants watch a video with non-moving images about colorectal cancer screening tests on an iPad.
Video with Animated Images
Participants watch a video with animated images about colorectal cancer screening tests on an iPad.
Questionnaires
Questionnaire completion before and after viewing the program.

Locations

Country Name City State
United States Bethel's Heavenly Hands Houston Texas
United States Ephiphany Community Health Outreach Services Houston Texas
United States Literacy Advance of Houston Houston Texas
United States University of Texas MD Anderson Cancer Center Houston Texas

Sponsors (2)

Lead Sponsor Collaborator
M.D. Anderson Cancer Center Foundation for Informed Medical Decision Making

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gist and Verbatim Knowledge for a Colorectal Cancer Screening Program The fixed effects analysis of variance (ANOVA) will utilize a factorial design with two factors: content presentation type (standard, animated, interactive) and numeracy status (high and low based on US population scores). Main dependent measures are gist and verbatim knowledge. Gist and verbatim knowledge scores (0-100) looked at separately as well as combined. 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A